Simulations Plus Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Private

  • Employees
  • 213

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 4

  • Investments
  • 8

Simulations Plus General Information

Description

Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Research Triangle Park
  • P.O. Box 12317
  • Durham, NC 27709
  • United States
+1 (661)
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • Research Triangle Park
  • P.O. Box 12317
  • Durham, NC 27709
  • United States
+1 (661)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Simulations Plus Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Simulations Plus‘s full profile, request access.

Request a free trial

Simulations Plus Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical re
Other Healthcare Technology Systems
Durham, NC
213 As of 2025

Menlo Park, CA
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Simulations Plus Competitors (4)

One of Simulations Plus’s 4 competitors is Pacific BioSciences of California, a Formerly VC-backed company based in Menlo Park, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pacific BioSciences of California Formerly VC-backed Menlo Park, CA
Bionano Genomics Formerly VC-backed San Diego, CA
Lonza Group Corporation Basel, Switzerland
SeraCare Formerly PE-Backed Milford, MA
To view Simulations Plus’s complete competitors history, request access »

Simulations Plus Patents

Simulations Plus Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024173096-A1 Simulation-based dynamic risk stratification Inactive 17-Feb-2023
US-6625585-B1 Method and system for artificial intelligence directed lead discovery though multi-domain agglomerative clustering Inactive 18-Feb-2000
US-20040117164-A1 Method and system for artificial intelligence directed lead discovery in high throughput screening data Inactive 19-Feb-1999
US-6904423-B1 Method and system for artificial intelligence directed lead discovery through multi-domain clustering Inactive 19-Feb-1999 G06N5/02

Simulations Plus Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Simulations Plus Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Simulations Plus‘s full profile, request access.

Request a free trial

Simulations Plus Investments & Acquisitions (8)

Simulations Plus’s most recent deal was a Later Stage VC with Nurocor for . The deal was made on 21-May-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Nurocor 21-May-2025 Later Stage VC Enterprise Systems (Healthcare)
Pro-ficiency 11-Jun-2024 Merger/Acquisition Other Healthcare Technology Systems
Immunetrics 16-Jun-2023 Merger/Acquisition Discovery Tools (Healthcare)
Lixoft 01-Apr-2020 Merger/Acquisition Business/Productivity Software
DILIsym Services 01-Jun-2017 Merger/Acquisition Other Healthcare Technology Systems
You’re viewing 5 of 8 investments and acquisitions. Get the full list »

Simulations Plus FAQs

  • When was Simulations Plus founded?

    Simulations Plus was founded in 1996.

  • Where is Simulations Plus headquartered?

    Simulations Plus is headquartered in Durham, NC.

  • What is the size of Simulations Plus?

    Simulations Plus has 213 total employees.

  • What industry is Simulations Plus in?

    Simulations Plus’s primary industry is Other Healthcare Technology Systems.

  • Is Simulations Plus a private or public company?

    Simulations Plus is a Private company.

  • What is the current valuation of Simulations Plus?

    The current valuation of Simulations Plus is .

  • What is Simulations Plus’s current revenue?

    The current revenue for Simulations Plus is .

  • How much funding has Simulations Plus raised over time?

    Simulations Plus has raised $5.75M.

  • Who are Simulations Plus’s investors?

    Altaris has invested in Simulations Plus.

  • Who are Simulations Plus’s competitors?

    Pacific BioSciences of California, Bionano Genomics, Lonza Group, and SeraCare are competitors of Simulations Plus.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process